Showing results (951-960 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|June 28, 2023
Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression ProfilesShilah A Bonnett, Alyssa B Rosenbloom, Giang T Ong, et al.Cancer Research Communications|June 28, 2023
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor ImmunityHong Jiang, Dong Ho Shin, Yanhua Yi, et al.Cancer Research Communications|February 5, 2024
Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast CancerNilesh Gardi, Rohan Chaubal, Pallavi Parab, et al.Cancer Research Communications|February 8, 2024
INHBA is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer ProgressionTsima Abou Kors, Linda Hofmann, Annika Betzler, et al.Cancer Research Communications|February 6, 2024
Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing AntibodiesHenry Chan, Christina V Trout, David Mikolon, et al.Cancer Research Communications|February 6, 2024
Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent MannerMariko Takami, Takahiro Aoki, Katsuhiro Nishimura, et al.Cancer Research Communications|February 9, 2024
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast CancerJonathan Goldberg, Na Qiao, Jennifer L Guerriero, et al.Cancer Research Communications|January 29, 2024
Longitudinal Position and Cancer Risk in the United States RevisitedJin Niu, Charlotte Brown, Michael Law, et al.Cancer Research Communications|July 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted TreatmentBeom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei, et al.Cancer Research Communications|July 24, 2023
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular CarcinomaStephanie L Alden, Mir Lim, Chester Kao, et al.Pageof 102